Geneos Wealth Management’s Cambria Cannabis ETF TOKE Stock Holding History

Geneos Wealth Management’s Portfolio TOKE Stock Details TOKE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-675	Closed	-$5K	–	2544
2022 Q2	$5K	Hold	675	–	–	﹤0.01%	2210
2022 Q1	$7K	Sell	675 -1,850	-73%	-$21.3K	﹤0.01%	2252
2021 Q4	$31K	Hold	2,525	–	–	﹤0.01%	1689
2021 Q3	$35K	Sell	2,525 -5,950	-70%	-$93.5K	﹤0.01%	1664
2021 Q2	$152K	Hold	8,475	–	–	0.01%	975
2021 Q1	$159K	Sell	8,475 -900	-10%	-$18.1K	﹤0.01%	1073
2020 Q4	$188K	Buy	9,375 +8,675	+1,239%	+$115K	0.01%	844
2020 Q3	$7K	Hold	700	–	–	﹤0.01%	2089
2020 Q2	$8K	Hold	700	–	–	﹤0.01%	2009
2020 Q1	$7K	Hold	700	–	–	﹤0.01%	1956
2019 Q4	$10K	Hold	700	–	–	﹤0.01%	1986
2019 Q3	$13K	Buy	+700	New	+$15.9K	﹤0.01%	1794

Other funds holding TOKE

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cambridge Advisors Omaha, Nebraska $582M AUM 19.14% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

GWS

Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Geneos Wealth Management's TOKE Position: Q3 2022 in Review

Geneos Wealth Management sold out of Cambria Cannabis ETF (TOKE) in Q3 2022, closing a stake of 675 shares — an estimated $5K sold.

Geneos Wealth Management first reported a position in TOKE in Q3 2019 and held it in 12 quarters. The position peaked at $188K in Q4 2020. 23 funds tracked by Wall St. Rank hold TOKE as of Q3 2022.

Geneos Wealth Management reported no remaining Cambria Cannabis ETF position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 675 Cambria Cannabis ETF shares in Q3 2022, an estimated $5K.
Geneos Wealth Management first reported a position in Cambria Cannabis ETF in Q3 2019 and held it in 12 quarters.
Geneos Wealth Management's Cambria Cannabis ETF position peaked at $188K in Q4 2020.
23 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.